150 filings
8-K
RVNC
Revance Therapeutics Inc
5 Mar 24
Other Events
5:08pm
8-K
RVNC
Revance Therapeutics Inc
28 Feb 24
Provides Corporate Update
4:07pm
8-K
RVNC
Revance Therapeutics Inc
13 Feb 24
Departure of Directors or Certain Officers
4:28pm
8-K
RVNC
Revance Therapeutics Inc
6 Feb 24
Departure of Directors or Certain Officers
4:04pm
8-K
RVNC
Revance Therapeutics Inc
8 Jan 24
Revance Provides Corporate Update, Preliminary Fourth Quarter and Full Year 2023 Financial Results, and Financial Outlook
8:01am
8-K
uxewy
15 Dec 23
Amendments to Articles of Incorporation or Bylaws
4:04pm
8-K
r282 nrnwve
8 Nov 23
Provides Corporate Update
4:09pm
8-K
g8oujczi
19 Sep 23
Revance Provides Corporate Update at Investor Day
9:01am
8-K
v2exg0qnvuhxpi3sot
30 Aug 23
Other Events
7:20pm
8-K
q7dfiq
14 Aug 23
Other Events
8:02am
8-K
4rsr5rjena3r7k4dwlo
8 Aug 23
Provides Corporate Update
4:08pm
8-K
bn7gu98xasoswi
9 May 23
Revance Reports First Quarter 2023 Financial Results, Provides Corporate Update
4:07pm
8-K
0w73vm4k8 xsn
8 May 23
Submission of Matters to a Vote of Security Holders
4:08pm
8-K
fk0fjy0o l9p
19 Apr 23
Regulation FD Disclosure
4:06pm
8-K
r6vaa12ouvz8rr1gt
28 Feb 23
Provides Corporate Update
4:10pm
8-K
m8hz 1hb1w
3 Feb 23
Departure of Directors or Certain Officers
4:05pm
8-K
95j2z2r9
18 Jan 23
Entry into a Material Definitive Agreement
4:48pm
8-K
h8f2 b8k39l
9 Jan 23
Revance Provides an Update on DAXXIFY® Commercial Launch and Preliminary Fourth Quarter and Full Year 2022 Financial Results
8:02am
8-K
9kqji77
8 Nov 22
Provides Corporate Update
4:06pm
8-K
3spjwkwu0l
20 Oct 22
Other Events
4:02pm